Blog
Prediction: These Could Be the Best-Performing Value Stocks Through 2030
As the stock market stays stuck in the artificial intelligence (AI) doldrums, hindering gains for growth stocks, now may be the time to shift focus toward value stocks.
Yes, value stocks present
Fund Builds $40 Million SPS Commerce Stake as Shares Sink 60% Despite 100 Straight Growth Quarters
Irenic Capital Management initiated a new position in SPS Commerce (NASDAQ:SPSC), acquiring 452,066 shares in the fourth quarter, according to a February 17, 2026, SEC filing.
Irenic Capital
Kaiser Aluminum (KALU) Q4 2025 Earnings Transcript
Image source: The Motley Fool.
Thursday, February 19, 2026 at 10 a.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
Ascendis (ASND) Q4 2025 Earnings Call Transcript
Image source: The Motley Fool.
Wednesday, February 11, 2026 at 4:30 p.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
As Stocks Slide, Here's 1 to Consider Buying
Major indexes were sliding Monday morning as recent news about tariffs has injected some uncertainty into the market. And this is on top of a software stock sell-off that has been gaining momentum
New Research Says: Apple Could Be Safe From AI Bubble Fears
Is Apple (NASDAQ: AAPL) a tech stock or not? Based on recent trends, Apple stock is not performing like the rest of the technology market. In the past six months, the iPhone maker's share price is
Ananym Capital Sells Out of $18 Million Six Flags Entertainment Position Amid the Stock's 63% Decline
According to a Securities and Exchange Commission (SEC) filing dated Feb. 17, 2026, Ananym Capital Management, LP, liquidated its entire holding of 795,411 shares in Six Flags Entertainment (NYSE:FU
Why Freshworks Stock Is Sinking Today
Continuing a decline that saw shares end Friday's session lower than the day before, Freshworks (NASDAQ: FRSH) stock is off to a bearish start this week. An analyst has taken a more pessimistic
Why American Express Plunged Today
Shares of credit card giant American Express (NYSE: AXP) plunged 7.5% on Monday as of 12:55 p.m. EDT.
It's unusual for such a big and seemingly strong company as American Express to fall this much
Should You Buy Apple Stock Before April 30?
For the first quarter of fiscal 2026 (ended Dec. 27), Apple (NASDAQ: AAPL) reported revenue and earnings per share (EPS) that blew past Wall Street analyst estimates. The top line grew by 15.7%,
Why Morgan Stanley Stock Dropped on Monday
Stock markets got rocked Monday, with the Dow down 1.3% amid concerns over a new report from Citrini Research, laying out economic risks from AI agents.
Financial giant Morgan Stanley (NYSE: MS)
Kymera Stock Up 130% as $135 Million Buy Boosts Immunology Bet
Baker Bros. Advisors reported a buy of 2,005,813 Kymera Therapeutics (NASDAQ:KYMR) shares in its February 17, 2026, SEC filing, an estimated $135.45 million trade based on quarterly average pricing.
Is SoundHound AI Stock a Buy Now?
SoundHound AI (NASDAQ: SOUN) has experienced considerable price movement in recent months. Shares of the voice-recognition specialist rose in the summer and fall of last year but has since given
Investor Buys Up $81 Million in Praxis Stock as Shares Soar Over 300% in One Year
On February 17, 2026, Baker Bros. Advisors LP disclosed a buy of 437,000 Praxis Precision Medicines (NASDAQ:PRAX) shares, estimated at $81.38 million based on quarterly average pricing.
According to
Fluor Dumps 71 Million SMR Shares for $1.35 Billion
On Feb. 13, 2026, Fluor Corp. (NYSE:FLR), a large shareholder of NuScale Power Corporation (NYSE:SMR), disclosed the sale of 71 million shares of common stock for a total consideration of ~$1.35
Why JPMorgan Stock Just Dropped
Tech stocks are tumbling Monday morning, with the Nasdaq down 1.1% on worries over a new AI report from Citrini Research -- and it's not only tech stocks suffering.
Financial giant JPMorgan Chase
Kodiak Sciences Stock Up 480% as One Fund Discloses $53 Million Buy
On February 17, 2026, Baker Bros. Advisors LP disclosed a buy of 2,608,696 shares of Kodiak Sciences (NASDAQ:KOD), an estimated $53.42 million trade based on quarterly average pricing.
According to
Home Depot Earnings Is Just a Day Away -- And Nearly 86% of Prediction Markets Expect Good News
Home Depot's (NYSE: HD) fourth-quarter earnings report is due out on Tuesday morning, and investors will be watching closely.
The leading home improvement retailer could use a win after suffering
Tencent Music’s Revenue Model Shifts Beyond Virtual Gifting as China’s Paid Music Market Expands
According to a Securities and Exchange Commission (SEC) filing dated February 12, 2026, Keystone Investors Pte Ltd sold its entire holding of 2,243,614 shares in Tencent Music Entertainment Group (N
This Fund Bet Nearly $40 Million on GRAIL Last Quarter. The Stock Just Plunged Over 50%
On February 17, 2026, Baker Bros. Advisors disclosed a purchase of 455,208 shares of GRAIL (NASDAQ:GRAL), an estimated $39.33 million trade based on quarterly average pricing.
According to a recent
Is Kalshi Likely to IPO in 2026?
Prediction markets have driven a lot of attention. These platforms allow prospective investors and speculators to trade on the outcomes of real-world events ranging from sporting events to elections
Social Security Has 2 Glaring Problems Right Now -- and They Could Jeopardize Your Retirement
Social Security is a lifeline for many retirees, with some relying on their benefits as their primary or even sole source of retirement income.
Unfortunately, the program isn't as reliable as it
The Top Tech Stocks to Buy in February
It might seem like a risky time to buy tech stocks. The S&P 500 still looks historically expensive at 30 times earnings, and most of its recent growth was driven by just a handful of tech giants.
Why Viking Therapeutics Stock Is Up More Than 9% Today
If you're looking for the company-specific headline that sent shares of Viking Therapeutics (NASDAQ: VKTX) soaring today, don't bother. You won't find one. Rather, investors are proverbially
Why ImmunityBio Stock Is Soaring Again Today
Shares of cancer immunotherapy specialist ImmunityBio (NASDAQ: IBRX) are up 16% as of noon ET on Monday after the company reported fourth-quarter earnings. The company's leading immunotherapy (and